Stages and duration of spermatogenesis in the domestic ferret (Mustela putorius furo).

Classification of seminiferous tubules is the basis for understanding normal and abnormal spermatogenesis. The aim of the present study was to determine spermatogenic stages and the duration of the cycle in the domestic ferret using bromodeoxyuridine (BrdU) as a tracer. Eleven adult male ferrets that were maintained in a breeding condition were used. Testicular sections were stained with the periodic acid-Schiff reaction for light microscopy. To determine the cycle duration, six ferrets were injected intraperitoneally with BrdU, and testes were collected 3h later and 10 days and 3h later. BrdU was detected by immunohistochemistry. Seminiferous tubules were classified into eight stages, and frequencies of stages I-VIII were 10.6, 2.2, 7.9, 13.1, 22.3, 21.9, 14.0 and 8.0%, respectively. The most advanced BrdU-labeled cells at 3h post-injection were leptotene spermatocytes in stage VI and those at 10 days and 3h were pachytene spermatocytes in stage V. From differences in stage frequency and BrdU staining frequency between two time points, the duration of one cycle was estimated to be 13.0 days. The present observations indicate that stages and the cycle duration of the ferret spermatogenesis are similar to those reported in other carnivores.

Clarification of emu serum for peptide hormone assay using polyethylene glycol precipitation.

Interference in radioimmunoassays (RIAs) was frequently encountered during endocrinological studies of the emu (Dromaius novaehollandiae). Interference was greatest when serum was cloudy or opaque. Such samples appeared seasonally, in spring and summer during the phase of fat deposition, and in the winter when females were laying. These poor quality samples did not allow accurate measurement by RIAs of several peptide hormones for a full year. To prepare them for assay, these sera were clarified using a polyethylene glycol (PEG) solution at a final concentration of 7.5%. This treatment was effective in most cases. After treatment with the PEG, recoveries of LH, glucagon, and prolactin were greater than 75% and that for insulin was 40%. Regardless of the level of recovery, there was a high correlation of assay results between non-opaque native and PEG-treated sera. Serum samples containing large amounts of interfering high molecular weight components, such as lipoproteins, can be clarified with PEG, enabling their accurate measurement by RIA.

Plasma thyroid hormones and growth hormone in embryonic and growing emus (Dromaius novaehollandiae).

Growth hormone (GH), thyroxine (T4) and tri-iodothyronine (T3) are known to be involved in the regulation of growth and development in a variety of avian species. It has been suggested that an absence of GH and thyroid hormones in ostriches is the cause of their neoteny, a phenomenon in which juvenile characteristics are retained into adulthood. Neoteny is typical of all ratites, the single group of flightless birds that includes the ostrich, but similar endocrine studies have not been performed for other members of the group, such as the emu. To test the neoteny hypothesis further, in the present study we measured the plasma concentrations of T4, T3 and GH in emus during embryonic development and from hatching to 1 year of age. Concentrations of T4 and GH increased during the last weeks of incubation, whereas concentrations of T3 were highly variable. After hatching, the concentrations of both thyroid hormones were high during the first 3 days of life and then fell to a constant low level. Plasma concentrations of GH were high at the time of hatching and decreased gradually over the first 22 weeks of age; thereafter, the concentrations of GH were highly variable. No correlation was observed between hormone concentrations and live weight at any time. These results support the hypothesis that thyroid function is abnormally low in ratites, whereas patterns of GH secretion are similar to those observed in other birds. Dysfunction of the thyroid axis could explain, in part, the neotenous physical aspect of adult emus.

Characterization of endocrine events during the periestrous period in sheep after estrous synchronization with controlled internal drug release (CIDR) device.

The Controlled Internal Drug Releasing (CIDR) device is an intravaginal pessary containing progesterone (P4) designed for synchronizing estrus in ruminants. To date, there has been little information available on the timing, duration, and quality of the follicular phase after CIDR removal and how those characteristics compare with natural periovulatory endocrine events. The present communication relates the results of methods we used to characterize the endocrine events that followed CIDR synchronization. Breeding-season ewes were given an injection (10 mg) of Lutalyse (PGF2 alpha), and then studied during three consecutive estrous cycles, beginning in the luteal phase after the estrus induced by PGF2 alpha. Cycle 1 estrus was synchronized with 1 CIDR (Type G) inserted for 8 d beginning 10 d after PGF2 alpha. Cycles 2 and 3 were synchronized with two CIDRs for 8 d beginning 10 d after previous CIDR removal. Cycle 1 estrous behavior and serum gonadotropins showed a follicular phase (the interval from CIDR withdrawal to gonadotropin surge [surge] peak) of 38.2 +/- 1.5 hr. Two CIDRs lengthened the interval to 46.2 +/- 1.5 hr (P < 0.0001). At CIDR removal, circulating P4 concentrations were higher in ewes treated with two CIDRs (5.1 +/- 0.3 and 6.4 +/- 0.4 ng/mL in Cycles 2 and 3 vs. 2.7 +/- 0.3 ng/mL in Cycle 1), whereas estradiol concentrations were higher in the 1 CIDR cycle (3.3 +/- 0.5 pg/mL in Cycle 1 vs. 0.5 +/- 0.1, and 0.7 +/- 0.2 pg/mL in Cycles 2 and 3), suggesting that the lower levels of P4 achieved with one CIDR was not sufficient to arrest follicular development. There were no differences in any other endocrine variable. Both one and two CIDR synchronization concentrated surges within a 24-hr period in 92% of the ewes in Cycles 1 and 2. Cycles 3 ewes were euthanized at estimated luteal, early follicular, late follicular, LH surge, and secondary FSH rise timepoints. Endocrine data and ovaries showed that 88% of the ewes synchronized with two CIDRs were in the predicted stage of the estrous cycle. These data demonstrate that the CIDR device applied during the luteal phase effectively synchronizes estrus and results in a CIDR removal-to-surge interval of similar length to a natural follicular phase.

Effects of administering progesterone at selected intervals after insemination of synchronized heifers on pregnancy rates and resynchronization of returns to service.

In 3 separate trials at 2 locations, dairy heifers (n = 396) were treated with a Controlled Internal Drug Release (CIDR) progesterone device for 9 d. On Day 7 of CIDR treatment, all heifers were injected with PGF(2alpha). Synchronized estruses were detected using a tailpaint and chalk (TPC) scoring system. An animal's tailhead was painted at device insertion, and this strip was covered with a contrasting color of chalk at device removal. Over all trials, 85.1% of the heifers were detected in estrus and were inseminated at 48 or 72 hours after CIDR removal. These synchronized and inseminated heifers were divided into the following treatment groups: 1) untreated controls, receiving no further treatment (n = 138); 2) post-insemination progesterone supplementation with a new (n = 59) or used (n = 29) CIDR device for Days 1 to 8 or 2 to 9, respectively, following insemination; or 3) resynchronization of return to service with a used CIDR device for Days 17 to 22 after insemination (n = 112). The pregnancy rate to first insemination in the control and resynchronized groups (Groups 1 and 3) was 46.4%, but decreased to 18.2% with the post-insemination progesterone supplementation. Resynchronization of returns to service (estrus detected 1 to 4 d following removal of second CIDR) occurred in 58.9% of all nonpregnant heifers in Group 3. In summary, CIDR devices used in conjunction with PGF(2alpha) effectively synchronize estrus in dairy heifers. Progesterone supplementation within 2 d of first insemination for 7 d suppressed fertility. Used CIDR devices inserted for Days 17 to 22 after first insemination resynchronized heifers not pregnant to first insemination.

Effects of postinsemination progesterone supplementation on fertility and subsequent estrous responses of dairy heifers.

The objective of Experiment I, replicated twice, was to evaluate whether fertility of estrus-synchronized dairy heifers could be improved by postinsemination progesterone supplementation. Estrous cycles were synchronized using two injections of prostaglandin (PG) F(2alpha) adiministered 11 days apart. Heifers displaying estrus were inseminated and assigned to control (n = 155) and treated (n = 159) groups. Treatment consisted of intravaginal insertion of controlled internal drug release (CIDR) devices for Days 7 to 13 (Day 0 = day of estrus). The conception rate for CIDR-treated heifers (57.9%) did not differ significantly from that of the controls (53.6%). The return-to-estrus rate and pattern of return estruses were not affected by treatment, but indicated that early embryonic mortality may have occurred in some of the heifers diagnosed nonpregnant. The objective of Experiment II was to evaluate if used CIDR devices were effective in resynchronizing returns to estrus in previously synchronized inseminated but nonpregnant and noninseminated heifers. Estrous cycles of dairy heifers of breeding age were synchronized with PGF(2alpha). Heifers displaying estrus were assigned to be inseminated (n = 117) or not inseminated (n = 35). All heifers were treated with 9-day used CIDR devices for Days 17 to 22 after synchronized estrus in order to resynchronize returns to estrus. Of the inseminated but nonpregnant heifers (n = 41), 78.1% were detected in estrus after CIDR removal (versus 94.3% of noninseminated heifers [n = 35]; P < 0.05) and 61.0% of the estruses occurred within 4 days of CIDR removal (versus 91.4% of noninseminated; P < 0.05). Estruses of synchronized inseminated nonpregnant heifers occurred over a longer period compared with those of noninseminated heifers (P < 0.025). The results indicate that response to the resynchronization protocol was altered by the outcome (early embryo death or failed fertilization) of the previous unsuccessful insemination, and support the hypothesis that delayed returns to estrus can be attributable to a pregnancy which was initiated but failed to establish itself. Such factors should be considered when evaluating responses of cattle to treatments designed to enhance fertility.